BIVRX | DIAYX | BIVRX / DIAYX | |
Total Expense Ratio | 3.42 | 1.34 | 255% |
Annual Report Gross Expense Ratio | 3.42 | 1.34 | 255% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | -3.656 | 9.370 | -39% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 500000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 910M | 1.95B | 47% |
Annual Yield % from dividends | 3.68 | 2.19 | 168% |
Returns for 1 year | -1.32 | 4.80 | -28% |
Returns for 3 years | -26.47 | 12.29 | -215% |
Returns for 5 years | 54.34 | 28.75 | 189% |
Returns for 10 years | N/A | 31.94 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CNPIX | 78.02 | N/A | N/A |
Consumer Staples UltraSector ProFund Inv | |||
VZICX | 31.37 | N/A | N/A |
Vanguard International Core Stock Adm | |||
FWOZX | 17.89 | N/A | N/A |
Fidelity Advisor Women's Leadership Z | |||
TEEFX | 83.36 | -0.25 | -0.30% |
T. Rowe Price Tax-Efficient Equity I | |||
AQGRX | 12.62 | -0.04 | -0.32% |
AQR Global Equity R6 |